CRAYON
Every story · every side  ·  est. 1995
Politics

The GLP-1 blind spot: Why the FDA’s new eye stroke warning matters

Photo: The Hill
▲ Sign in to vote stories up

Coverage 1 source · 1 report

Chronological.

  1. The Hill FIRST 2h ago The GLP-1 blind spot: Why the FDA’s new eye stroke warning matters

    It forces the medical community to treat these therapies with clinical gravity instead of casual enthusiasm.

Discussion 0 comments